Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8212-7. doi: 10.1073/pnas.1206062109. Epub 2012 May 7.
The large chromosomal deletions frequently observed in cancer genomes are often thought to arise as a "two-hit" mechanism in the process of tumor-suppressor gene (TSG) inactivation. Using a murine model system of hepatocellular carcinoma (HCC) and in vivo RNAi, we test an alternative hypothesis, that such deletions can arise from selective pressure to attenuate the activity of multiple genes. By targeting the mouse orthologs of genes frequently deleted on human 8p22 and adjacent regions, which are lost in approximately half of several other major epithelial cancers, we provide evidence suggesting that multiple genes on chromosome 8p can cooperatively inhibit tumorigenesis in mice, and that their cosuppression can synergistically promote tumor growth. In addition, in human HCC patients, the combined down-regulation of functionally validated 8p TSGs is associated with poor survival, in contrast to the down-regulation of any individual gene. Our data imply that large cancer-associated deletions can produce phenotypes distinct from those arising through loss of a single TSG, and as such should be considered and studied as distinct mutational events.
在癌症基因组中经常观察到的大型染色体缺失通常被认为是肿瘤抑制基因(TSG)失活过程中的“两次打击”机制。我们使用肝细胞癌(HCC)的小鼠模型系统和体内 RNAi 来测试另一种假设,即这种缺失可能是由于选择性压力而削弱多个基因的活性而产生的。通过靶向人类 8p22 上经常缺失的基因的小鼠同源基因以及相邻区域,这些基因在其他几种主要上皮癌中丢失了约一半,我们提供了证据表明 8p 上的多个基因可以在小鼠中协同抑制肿瘤发生,并且它们的共抑制可以协同促进肿瘤生长。此外,在人类 HCC 患者中,功能验证的 8p TSG 的联合下调与生存不良相关,而不是单个基因的下调。我们的数据表明,与单个 TSG 丧失引起的表型相比,大型与癌症相关的缺失可产生明显不同的表型,因此应将其视为不同的突变事件并进行研究。